Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
142 studies found for:    Acromegaly
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Lanreotide Levels in Acromegaly
Condition: Acromegaly
Intervention: Other: Blood draw
2 Recruiting Treatment Patterns and Treatment Outcomes for Acromegaly
Condition: Acromegaly
Intervention:
3 Not yet recruiting The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness Research
Condition: Acromegaly
Interventions: Procedure: Transnasal butterfly surgery;   Drug: sandostatin;   Radiation: radiotherapy
4 Completed Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study
Condition: Acromegaly
Intervention:
5 Approved for marketing An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
Condition: Acromegaly
Intervention: Drug: Pasireotide long acting release formulation
6 Recruiting A Prospective Study of Outcome After Therapy for Acromegaly
Condition: Acromegaly
Interventions: Procedure: Surgery for acromegaly;   Drug: Medications for acromegaly
7 Completed Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR
Condition: Acromegaly
Intervention: Drug: Lanreotide (Autogel formulation)
8 Completed Surgical Versus Medical Treatment of Acromegaly
Condition: Acromegaly
Intervention:
9 Completed Clomiphene Citrate for Treatment of Acromegaly
Condition: Acromegaly
Intervention: Drug: Clomiphene Citrate
10 Completed Treatment of Acromegaly With Somatostatin Analogs: GH vs. IGF-I as Primary Biochemical Target
Condition: Acromegaly
Intervention: Drug: Sandostatin® LAR
11 Unknown  Ultrasound Guided Sandostatin LAR Injection in Acromegaly
Condition: Acromegaly
Intervention: Drug: Sandostatin LAR
12 Completed Effect of Growth Hormone (GH) on Cardiac Echos in GH Deficient Patients After Acromegaly Treatment
Condition: Acromegaly
Intervention:
13 Unknown  A Study Examining the Peri- and Post-operative Dynamics of the Growth Hormone (GH) - IGF-1 Axis in Subjects With Acromegaly During the First Year After Surgical Resection
Condition: Acromegaly
Intervention: Other: OGTT
14 Unknown  Epidemiology of Acromegaly in Denmark 1991-2010
Condition: Acromegaly
Intervention:
15 Completed Fractionated Stereotactic Radiotherapy in Patients With Acromegaly
Condition: Acromegaly
Intervention: Radiation: fractionated stereotactic radiotherapy
16 Active, not recruiting Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues
Condition: Acromegaly
Intervention: Drug: Pasireotide LAR
17 Unknown  Acromegaly & Sleep Apnoea
Condition: Acromegaly
Intervention:
18 Completed Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly
Condition: Acromegaly
Intervention: Drug: Octreotide-LAR
19 Completed
Has Results
Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly
Condition: Acromegaly
Interventions: Drug: Pasireotide;   Drug: Octreotide
20 Recruiting Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly
Condition: Acromegaly
Interventions: Drug: Octreotide capsules;   Drug: Injectable Somatostatin Analogs (octreotide or lanreotide);   Drug: Cabergoline

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.